Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eiger Biopharma (NQ: EIGR )

10.75 USD +0.20 (+1.85%)
Streaming Delayed Price Updated: 11:17 AM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 57,970
Open 10.46
Bid (Size) 10.68 (7)
Ask (Size) 10.76 (1)
Prev. Close 10.55
Today's Range 10.43 - 10.76
52wk Range 4.550 - 14.79
Shares Outstanding 10,540,121
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Plans
- Phase 3 HDV D-LIVR (Lonafarnib) Planned to Complete Enrollment in 2021 
From PR Newswire
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy™ (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
- Zokinvy increases survival by 2.5 years in children and young adults with Progeria 
From PR Newswire

Performance

YTD
-11.93%
-11.93%
1 Month
+6.07%
+6.07%
3 Month
+7.88%
+7.88%
6 Month
+6.39%
+6.39%
1 Year
-24.54%
-24.54%

More News

Read More
Eiger BioPharmaceuticals Sells Priority Review Voucher for $95 Million
From PR Newswire
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy™ (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
From PR Newswire
Eiger Announces Positive Peginterferon Lambda - Lonafarnib Combination End of Study Results from Phase 2 LIFT HDV Study in Late-Breaker Session at The Liver Meeting Digital Experience™ 2020
From PR Newswire
Eiger Announces Case Studies Demonstrating Regression of Liver Fibrosis Following 48 Weeks of Therapy with Peginterferon Lambda in Patients with Chronic Hepatitis Delta Virus (HDV) Infection Presented
From PR Newswire
Eiger Bio to Participate in November 2020 Investor Conferences
From PR Newswire
Notable Monday Option Activity: SDGR, EIGR, UFS
Tags Stocks
From Market News Video
FDA Approves Eiger Biopharma's Progeria Treatment: What Investors Should Know
Tags General Trading Ideas MRK
From Benzinga
12 Healthcare Stocks Moving In Monday's Pre-Market Session
Tags ARTL DBVT NMTR
From Benzinga
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.